This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fukumura, D. Articles by Jain, R. K. Search for Related Content PubMed PubMed Citation Articles by Fukumura, D. Articles by Jain, R. K.

Tumor Necrosis Factor -induced Leukocyte Adhesion in Normal and Tumor Vessels: Effect of Tumor Type, Transplantation Site, and Host Strain¹

Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114 [D. F., H. A. S., B. W., R. J. M., R. K. J.], and Departments of Physiology and Neurosurgery, Temple University School of Medicine, Philadelphia, Pennsylvania 19140 [R. F. T.]

Tumor necrosis factor (TNF-) can lead to tumor regression when injected locally or when used in an isolated limb perfusion, and it can enhance the tumoricidal effect of various therapies. TNF- can also up-regulate adhesion molecules and, thus, facilitate the binding of leukocytes to normal vessels. The present study was designed to investigate the extent to which the host leukocytes roll and adhere to vessels of different tumors (MCaIV, a murine mammary adenocarcinoma; HGL21, a human malignant astrocytoma) at a given site or to the same tumor at different sites (dorsal skin and cranium), in different mouse strains [C3H and severe combined immunodeficient (SCID)], both with and without TNF--activation. There was no significant difference in hemodynamic parameters such as RBC velocity, diameter, or shear rate between PBS-treated control groups and corresponding TNF--treated groups. Under PBS control conditions, the leukocyte rolling count in MCaIV tumor vessels in the dorsal chamber in C3H and SCID mice and in the cranial window in C3H mice was significantly lower than that in normal vessels (P < 0.05), but stable cell adhesion was similar between normal and tumor vessels. TNF- led to an increase (P < 0.05) in leukocyte-endothelial interaction in vessels in the following cases: normal tissue regardless of sites and strains, MCaIV tumor in the dorsal chamber in C3H and SCID mice, MCaIV tumor in the cranial window in C3H mice, and HGL21 tumor in the cranial window in SCID mice. However, the increase in rolling and adhesion in the MCaIV tumor in response to TNF- was significantly lower than in the corresponding normal vessels (P < 0.05) in the dorsal chamber in C3H and SCID mice and in the cranial window in C3H mice. The HGL21 tumor in the cranial window in SCID mice showed leukocyte rolling and adhesion comparable to that in normal pial vessels. These findings suggest that (a) in general, basal leukocyte rolling is lower in tumor vessels than in normal vessels; (b) leukocyte rolling and adhesion in tumors can be enhanced by TNF--mediated activation; and (c) the TNF- response is dependent on tumor type, transplantation site, and host strain. These results have significant implications in the gene therapy of cancer using TNF--gene-transfected cancer cells or lymphocytes.

¹ This work was supported by an American Cancer Society grant (to R. K. J.). D. F. is a DuPont Merck Fellow.

² Authors contributed equally to this paper.

Received 7/24/95. Accepted 8/28/95.

This article has been cited by other articles:

				J. Jiang, R. Goel, M. A. Iftekhar, R. Visaria, J. D. Belcher, G. M. Vercellotti, and J. C. Bischof Tumor necrosis factor-{alpha}-induced accentuation in cryoinjury: mechanisms in vitro and in vivo Mol. Cancer Ther., August 1, 2008; 7(8): 2547 - 2555. [Abstract] [Full Text] [PDF]

				R. Goel, D. Swanlund, J. Coad, G. F. Paciotti, and J. C. Bischof TNF-{alpha}-based accentuation in cryoinjury--dose, delivery, and response Mol. Cancer Ther., July 1, 2007; 6(7): 2039 - 2047. [Abstract] [Full Text] [PDF]

				A. E. M. Dirkx, M. G. A. oude Egbrink, J. Wagstaff, and A. W. Griffioen Monocyte/macrophage infiltration in tumors: modulators of angiogenesis J. Leukoc. Biol., December 1, 2006; 80(6): 1183 - 1196. [Abstract] [Full Text] [PDF]

				S. I. Zittermann and A. C. Issekutz Basic Fibroblast Growth Factor (bFGF, FGF-2) Potentiates Leukocyte Recruitment to Inflammation by Enhancing Endothelial Adhesion Molecule Expression Am. J. Pathol., March 1, 2006; 168(3): 835 - 846. [Abstract] [Full Text] [PDF]

				J. M. McLoughlin, T. M. McCarty, C. Cunningham, V. Clark, N. Senzer, J. Nemunaitis, and J. A. Kuhn TNFerade, an Adenovector Carrying the Transgene for Human Tumor Necrosis Factor {alpha}, for Patients With Advanced Solid Tumors: Surgical Experience and Long-Term Follow-Up Ann. Surg. Oncol., October 1, 2005; 12(10): 825 - 830. [Abstract] [Full Text] [PDF]

				M. Uutela, M. Wirzenius, K. Paavonen, I. Rajantie, Y. He, T. Karpanen, M. Lohela, H. Wiig, P. Salven, K. Pajusola, et al. PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis Blood, November 15, 2004; 104(10): 3198 - 3204. [Abstract] [Full Text] [PDF]

				N. Senzer, S. Mani, A. Rosemurgy, J. Nemunaitis, C. Cunningham, C. Guha, N. Bayol, M. Gillen, K. Chu, C. Rasmussen, et al. TNFerade Biologic, an Adenovector With a Radiation-Inducible Promoter, Carrying the Human Tumor Necrosis Factor Alpha Gene: A Phase I Study in Patients With Solid Tumors J. Clin. Oncol., February 15, 2004; 22(4): 592 - 601. [Abstract] [Full Text] [PDF]

				A. E. M. Dirkx, M. G. A. oude Egbrink, M. J. E. Kuijpers, S. T. van der Niet, V. V. T. Heijnen, J. C. A. B.-t. Steege, J. Wagstaff, and A. W. Griffioen Tumor Angiogenesis Modulates Leukocyte-Vessel Wall Interactions in Vivo by Reducing Endothelial Adhesion Molecule Expression Cancer Res., May 1, 2003; 63(9): 2322 - 2329. [Abstract] [Full Text] [PDF]

				P. Algenstaedt, C. Schaefer, T. Biermann, A. Hamann, B. Schwarzloh, H. Greten, W. Ruther, and N. Hansen-Algenstaedt Microvascular Alterations in Diabetic Mice Correlate With Level of Hyperglycemia Diabetes, February 1, 2003; 52(2): 542 - 549. [Abstract] [Full Text] [PDF]

				T. M. Carlos Leukocyte recruitment at sites of tumor: dissonant orchestration J. Leukoc. Biol., August 1, 2001; 70(2): 171 - 184. [Abstract] [Full Text] [PDF]

				H. Zhang and A. C. Issekutz Growth factor regulation of neutrophil-endothelial cell interactions J. Leukoc. Biol., August 1, 2001; 70(2): 225 - 232. [Abstract] [Full Text] [PDF]

				H. Irjala, M. Salmi, K. Alanen, R. Grenman, and S. Jalkanen Vascular Adhesion Protein 1 Mediates Binding of Immunotherapeutic Effector Cells to Tumor Endothelium J. Immunol., June 1, 2001; 166(11): 6937 - 6943. [Abstract] [Full Text] [PDF]

				O. Christ, S. Matzku, C. Burger, and M. Zöller Interleukin 2-Antibody and Tumor Necrosis Factor-Antibody Fusion Proteins Induce Different Antitumor Immune Responses in Vivo Clin. Cancer Res., May 1, 2001; 7(5): 1385 - 1397. [Abstract] [Full Text]

				Y. Tsuzuki, D. Fukumura, B. Oosthuyse, C. Koike, P. Carmeliet, and R. K. Jain Vascular Endothelial Growth Factor (VEGF) Modulation by Targeting Hypoxia-inducible Factor-1{{alpha}} {->} Hypoxia Response Element {->} VEGF Cascade Differentially Regulates Vascular Response and Growth Rate in Tumors Cancer Res., November 1, 2000; 60(22): 6248 - 6252. [Abstract] [Full Text]

				F. M. Yakes, B. D. Wamil, F. Sun, H.-P. Yan, C. E. Carter, and C. G. Hellerqvist CM101 Treatment Overrides Tumor-induced Immunoprivilege Leading to Apoptosis Cancer Res., October 1, 2000; 60(20): 5740 - 5746. [Abstract] [Full Text]

				A. W. Griffioen and G. Molema Angiogenesis: Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation Pharmacol. Rev., June 1, 2000; 52(2): 237 - 268. [Abstract] [Full Text] [PDF]

				S. C. Tromp, M. G. A. oude Egbrink, R. P. M. Dings, S. van Velzen, D. W. Slaaf, H. F. P. Hillen, G. J. Tangelder, R. S. Reneman, and A. W. Griffioen Tumor angiogenesis factors reduce leukocyte adhesion in vivo Int. Immunol., May 1, 2000; 12(5): 671 - 676. [Abstract] [Full Text] [PDF]

				R. R. Langley, J. Russell, M. J. Eppihimer, S. J. Alexander, M. Gerritsen, R. D. Specian, and D. N. Granger Quantification of murine endothelial cell adhesion molecules in solid tumors Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H1156 - H1166. [Abstract] [Full Text] [PDF]

				W. L. Monsky, D. Fukumura, T. Gohongi, M. Ancukiewcz, H. A. Weich, V. P. Torchilin, F. Yuan, and R. K. Jain Augmentation of Transvascular Transport of Macromolecules and Nanoparticles in Tumors Using Vascular Endothelial Growth Factor Cancer Res., August 1, 1999; 59(16): 4129 - 4135. [Abstract] [Full Text] [PDF]

				A. Tsujikawa, Y. Ogura, N. Hiroshiba, K. Miyamoto, J. Kiryu, Y. Honda, and V. L. Dawson Tacrolimus (FK506) Attenuates Leukocyte Accumulation After Transient Retinal Ischemia • Editorial Comment Stroke, July 1, 1998; 29(7): 1431 - 1438. [Abstract] [Full Text] [PDF]

				R. E. Gerszten, F. W. Luscinskas, H. T. Ding, D. A. Dichek, L. M. Stoolman, M. A. Gimbrone Jr, and A. Rosenzweig Adhesion of Memory Lymphocytes to Vascular Cell Adhesion Molecule-1–Transduced Human Vascular Endothelial Cells Under Simulated Physiological Flow Conditions In Vitro Circ. Res., December 1, 1996; 79(6): 1205 - 1215. [Abstract] [Full Text]